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We would like to thank Dr Apostolakis for his valuable
comment on our recently published results on procalcitonin
(PCT) in the postoperative course after decortication in case
of pleural empyema [1,2].
The point of the study was the observation of the
postoperative course of PCT in comparison to CrP. We
registered that PCT seems ‘to reflect the postoperative
clinical course more accurately than CrP’ and has had ‘a good
correlation with the postoperative course in case of SIRS or
sepsis’ [2].On theotherhand lowpreoperative levels ofPCT, as
was the case in two patients (9.1%), do not exclude a localized
(without systemic signs) infection. The patient with the
postoperative recurrent pleural effusions showed a preopera-
tive level of 0.35 ng/ml. This is not a low level but rather a sign
of an infection, yet not necessarily a systemic one (serum or
plasma PCT concentrations of healthy persons are measured
with the Kryptor-assay are below 0.06 ng/ml [3]).
If there was only the sneaking suspicion that a pleural
empyema was due to tuberculosis (clinic, anamnesis) this
patient was excluded from the trial from the beginning of
treatment. So not one of the patients in the presented study
had tuberculosis.
We are sure that in case of an earlier availability of the
PCT values most of the patients with an antibiotic treatment
after discharge would not have received antibiotics (up to
85.7%). ‘So the use of PCT instead of CrP in the postoperative
course after decortication could save at least 7 days of
antibiotic treatment’ [2]. This is in accordance with other
trials [4,5].
Indeed, the number of patients is small, in this
prospective, but not randomized trial. And it is known that
PCT levels show a wide variation but: ‘In general dynamics of
PCT levels, rather than the absolute values, may be more
important for identifying patients with persistent infection or
infectious complications after surgery’ [2].
Therefore we also think it is very important to have
randomized studies with more patients, maybe in a multi-
center trial. These studies should determine the value of PCT
as a promising marker in thoracic surgery not only after
decortication in case of pleural empyema.
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We readwith great interest the article by Dreyfus et al. on
tricuspid leaflet augmentation in functional tricuspid
regurgitation [1]. We congratulate the authors for their
innovative approach to relieve tethering-induced functional
tricuspid regurgitation and their excellent results. As
mentioned by the authors, inadequate tricuspid leaflet
coaptation has been shown to arise from annulus dilatation
greater than 40 mm and tethering of the valve leaflets in
functional tricuspid regurgitation. Annuloplasty addresses
annular dilatation, however it has not been shown to
improve leaflet tethering. Several authors have proposed
valve repair techniques to address severe tethering, such as
a tricuspid version of the Alfieri repair or ‘clover’ technique
[2] or right ventricular remodeling [3]. The method
described by Dreyfus et al. is innovative, in that it is the
first to increase leafletmobility and coaptation in the dilated
right ventricle. However, paraphrasing the author’s own
remarks on functionalmitral regurgitation repair at the 22nd
EACTS meeting, this remains a valvular approach to a
ventricular problem. Furthermore, Park et al. recently
showed in a real-time 3D echocardiographic study of 54
patients with functional tricuspid regurgitation [4] that
tethering was predominantly due to the septal leaflet, and
not the anterior leaflet. These results are counter-intuitive,
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more logical explanation for tethering, resulting in pre-
dominantly anterior leaflet tethering.
Anterior leaflet augmentation should increase leaflet
coaptation and decrease tethering height and tenting
volume. However, given the new data provided by Park
et al., this repair will significantly displace the coaptation
plane closer to the septum, with a possible risk of dynamic
RVOT obstruction, and it will not restore a completely
physiological function to the tricuspid valve. The risk of
lesions to the atrioventricular node precludes septal leaflet
enlargement similar to the technique described. The fate of
untreated autologous pericardium in the long-term should be
assessed, as deterioration could lead to decreased anterior
leaflet mobility and repair failure. Another possible strategy
to treat tethering would be to suspend the septal leaflet free
edge to the native anterior annulus or anterior annuloplasty
ring, as we have reported in posterior leaflet retraction of the
mitral valve [5] and as we have used successfully in two
patients with tricuspid septal leaflet tethering in Ebstein’s
anomaly.
We congratulate the authors on their innovative and
thoughtful approach to a complex problem. Further research
into the mechanisms of functional tricuspid regurgitation
is warranted and surgical strategies to treat them
should be adapted. We humbly suggest, given the latest
echocardiographic data on the mechanisms of tricuspid
tethering, that perhaps septal leaflet augmentation would
provide a more physiological solution, although it does
not appear realistically feasible. Anterior leaflet augmen-
tation should be considered a reasonable alternative,
keeping in mind the alterations to the function of the
tricuspid valve.
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We are grateful to Myers et al. [1] for their appreciation of
our innovative technique [2] and more importantly for
providing us the opportunity to address key issues relevant to
the understanding of this technique as well as the
pathophysiology of functional tricuspid regurgitation (FTR).
Septal leaflet lacks a well-defined papillary muscle and is
attached to the interventricular septum through chordae,
each of which has its own rudimentary papillary muscle.
Augmentation of septal leaflet is unlikely to achieve the
desired results of elimination of residual/recurrent regur-
gitation as increase in surface area of the septal leaflet will
be negated by its limited excursion due to lack of papillary
muscle. Moreover, when tethering is present the septal shift
is minimal as opposed to movement of the anterior free wall
of the right ventricle (RV) that is themajor contributor to this
process.
Suspension of the septal leaflet free edge to the native
anterior annulus or anterior annuloplasty ring is no doubt a
potential strategy but unfortunately not an ideal strategy to
tackle severe leaflet tethering. This is for two reasons.
Firstly, this technique puts the tissues under increased
tension and restricts leaflet motion. Secondly and more
importantly it fails to increase the coaptation surface, which
is the primary pathology in tethering. On the contrary, our
technique is unique amongst existing strategies as it not only
avoids these aforementioned drawbacks but also preserves
the functional relationship of the tricuspid valve leaflets by
ensuring coaptation not at its theoretical level but as deep as
needed into the RV cavity.
We acknowledge the comment of Myers et al. [1]
regarding the fate of untreated autologous pericardium in
the long-term. However, we will take this opportunity to
clarify that use of untreated autologous pericardium is not by
choice but due to health and safety regulations in United
Kingdom that prohibit use of glutaraldehyde in the work
place.
As for dynamic right ventricular outflow tract obstruction
(RVOTO) after the use of our technique, we will like to
mention that RVOTO is impossible due to simple anatomical
facts, which differentiate the right ventricle from the left
ventricle. Firstly, there is a lack of continuity between the
anterior leaflet of tricuspid valve and pulmonary valve
annulus unlike the anterior leaflet of mitral valve and its
continuity with the aortic valve annulus [3]. Secondly, the
inflow tract and outflow tract in the right ventricle are
distinct due to the presence of supraventricular crest unlike
the left ventricle where no such distinction is present. Thus,
due to these anatomical arrangements whereas dynamic left
